COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room
Open Access
- 20 April 2021
- journal article
- editorial
- Published by Elsevier BV in The Lancet Microbe
- Vol. 2 (7), e279-e280
- https://doi.org/10.1016/s2666-5247(21)00069-0
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingThe New England Journal of Medicine, 2021
- Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical TrialsMedicina, 2021
- What does 95% COVID-19 vaccine efficacy really mean?The Lancet Infectious Diseases, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineThe New England Journal of Medicine, 2021
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in RussiaThe Lancet, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine, 2020
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKThe Lancet, 2020